We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCSG icon
301
Healthcare Services Group
HCSG
$1.59B
$613K 0.06%
20,818
– –
MCO icon
302
Moody's
MCO
$84.3B
$608K 0.06%
6,940
+1,500
+28% +$124K
CNQR
303
DELISTED
CONCUR TECHNOLOGIES INC
CNQR
$608K 0.06%
6,515
+1,400
+27% +$123K
ARRS
304
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$602K 0.06%
18,491
-10,784
-37% -$319K
GEN icon
305
Gen Digital
GEN
$16.7B
$600K 0.06%
26,196
-4,600
-15% -$97.8K
CRZO
306
DELISTED
Carrizo Oil & Gas Inc
CRZO
$600K 0.06%
8,666
+4,860
+128% +$282K
PDLI
307
DELISTED
PDL BioPharma, Inc.
PDLI
$599K 0.06%
61,899
+24,350
+65% +$217K
APC
308
DELISTED
Anadarko Petroleum
APC
$597K 0.06%
5,450
-3,600
-40% -$366K
LAZ icon
309
Lazard
LAZ
$4.05B
$596K 0.06%
11,569
– –
EHC icon
310
Encompass Health
EHC
$11.4B
$595K 0.06%
20,845
– –
SHW icon
311
Sherwin-Williams
SHW
$84.5B
$591K 0.06%
8,574
+2,700
+46% +$180K
DEI icon
312
Douglas Emmett
DEI
$2.09B
$587K 0.06%
20,810
-4,400
-17% -$122K
HIW icon
313
Highwoods Properties
HIW
$3.87B
$585K 0.06%
13,935
-2,150
-13% -$86.5K
LNG icon
314
Cheniere Energy
LNG
$54.1B
$581K 0.06%
8,100
+2,700
+50% +$164K
LTM
315
DELISTED
LIFE TIME FITNESS INC
LTM
$581K 0.06%
11,911
-1,550
-12% -$76.1K
PRU icon
316
Prudential Financial
PRU
$43.1B
$580K 0.06%
6,530
-3,200
-33% -$269K
BDX icon
317
Becton Dickinson
BDX
$46.2B
$575K 0.06%
4,982
+1,128
+29% +$128K
KWR icon
318
Quaker Houghton
KWR
$2.55B
$574K 0.06%
7,471
+360
+5% +$27.3K
COR icon
319
Cencora
COR
$62.6B
$572K 0.06%
7,870
+1,900
+32% +$130K
ACET
320
DELISTED
Aceto Corp
ACET
$572K 0.06%
31,548
– –
HLT icon
321
Hilton Worldwide
HLT
$72.3B
$571K 0.06%
8,167
– –
LUV icon
322
Southwest Airlines
LUV
$22B
$570K 0.06%
21,230
+6,400
+43% +$161K
MEI icon
323
Methode Electronics
MEI
$480M
$569K 0.06%
14,890
-2,920
-16% -$89.3K
OMC icon
324
Omnicom Group
OMC
$23.7B
$569K 0.06%
7,990
-5,418
-40% -$377K
USG
325
DELISTED
Usg
USG
$569K 0.06%
18,869
-7,855
-29% -$240K
11 12
13
14 15

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.